Philip Morris International Inc. (PM) is a consumer-staples stock, not an ETF. Because the average analyst price target of roughly $211 is barely above the latest close, it fails the standard test for a useful "can it reach" question. The $230 figure is therefore presented as a publicly discussed price objective — the high end of the current analyst range — rather than a consensus forecast.
For context, data aggregators report roughly 15 to 16 covering analysts with a "Buy" consensus and an average 12-month target near $210, within a range of about $175 to $230. Individual, dated targets include Barclays at $225, Citigroup at $225, Goldman Sachs at $222, Argus Research at $220, Needham at $220, Morgan Stanley at $215, and Bank of America at $211. More cautious views include UBS at $201 (Neutral) and Stifel at $205, while older targets from Jefferies ($180) and J.P. Morgan ($185) anchor the lower end. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
Shares last closed near $208.79, within a 52-week range of roughly $142.11 to $214.35. Reaching $230 would require an advance of about 10% — a modest move for a large-cap staple, but one that would require a decisive break above the recent record-high zone near $214 before any approach to $230 becomes realistic.
The fundamental backdrop is mixed. Philip Morris beat third-quarter estimates on strong smoke-free demand and tobacco pricing, but management trimmed its 2026 adjusted EPS guidance to a range of roughly $8.29 to $8.44, citing global conflicts and a clouded outlook. ZYN shipment growth has been exceptional, and smoke-free products now contribute about 40% of revenue, but the stock already trades at a premium P/E near 30 times trailing earnings.
PM's most durable reference points are the 52-week low near $142 and the record high near $214, the latter acting as immediate resistance. The round-number $200 level has served as both support and a psychological marker, while the $191 to $196 zone corresponds to recent longer-term moving averages. A sustained close above $214 would be the first meaningful sign that a move toward $230 is developing, whereas a breakdown below $200 would likely reset the discussion toward the lower end of the analyst range.
Analyst price targets typically reflect a roughly 12-month research horizon, though individual firms do not always state a fixed timeframe. Investors should watch upcoming quarterly results and guidance updates, analyst target revisions, currency moves (given PM's substantial international revenue), regulatory decisions on nicotine products, and ZYN and IQOS shipment trends. Any acceleration — or stall — in smoke-free volume growth is likely to be the single most important driver of whether the shares can extend toward $230. From what I see, this is important because it ties directly to the company's transformation narrative.
The $230 objective is the high end of the current analyst price-target range, not an average or consensus, and it implies a roughly 10% advance from the latest price near $208.79. The bull case rests on exceptional smoke-free growth and strong pricing, while the bear case centers on trimmed guidance, currency headwinds, a premium valuation, and regulatory uncertainty. The wide $175-to-$230 analyst range underscores real disagreement about how much the transformation is worth. Reaching $230 is possible, but it would require clearing the recent record high and sustaining smoke-free momentum against a demanding valuation — an outcome that is far from guaranteed.
In my analysis of names like PM, I often turn to Tickeron’s AI Daily Buy/Sell Signals to track shifts in technical behavior alongside the fundamentals. The platform monitors thousands of stocks in real time, helping surface potential entry or exit points based on AI-driven signals. It has become a useful complement to traditional research when evaluating whether momentum is building toward a target like $230.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
PM moved above its 50-day moving average on October 05, 2026 date and that indicates a change from a downward trend to an upward trend. In 24 of 37 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are 65%.
The Momentum Indicator moved above the 0 level on October 29, 2026. You may want to consider a long position or call options on PM as a result. In 40 of 78 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 51%.
The Moving Average Convergence Divergence (MACD) for PM just turned positive on October 29, 2026. Looking at past instances where PM's MACD turned positive, the stock continued to rise in 27 of 49 cases over the following month. The odds of a continued upward trend are 55%.
Following a +3.03% 3-day Advance, the price is estimated to grow further. Considering data from situations where PM advanced for three days, in 233 of 389 cases, the price rose further within the following month. The odds of a continued upward trend are 60%.
The Aroon Indicator entered an Uptrend today. In 166 of 328 cases where PM Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 51%.
The 10-day RSI Indicator for PM moved out of overbought territory on October 15, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 44 similar instances where the indicator moved out of overbought territory. In 19 of the 44 cases, the stock moved lower in the following days. This puts the odds of a move lower at 43%.
The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where PM declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 45%.
PM broke above its upper Bollinger Band on October 29, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron SMR rating for this company is 3 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 5 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 68, placing this stock better than average.
The Tickeron PE Growth Rating for this company is 11 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 15 (best 1 - 100 worst), indicating outstanding price growth. PM’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 48 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: PM's P/B Ratio (-37.915) is slightly lower than the industry average of (-7.574). P/E Ratio (29.999) is within average values for comparable stocks, (13.112). Projected Growth (PEG Ratio) (2.327) is also within normal values, averaging (3.595). Dividend Yield (0.031) settles around the average of (0.059) among similar stocks. PM's P/S Ratio (7.022) is slightly higher than the industry average of (2.780).
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a manufacturer of cigarettes and other tobacco products
Industry Tobacco